Dr. Spenner is a member of the firm, based in the Chicago office. Specializing in the fields of biotechnology, pharmaceuticals, and chemistry, Dr. Spenner brings extensive legal experience and deep scientific understanding to his patent law practice.
Dr. Spenner has counseled and managed international patent portfolios for pharmaceutical companies, biotechnology companies, and academic institutions, with the size of clients ranging from large multinational corporations to start-ups. Dr. Spenner has experience in the drafting and prosecution of U.S. and international patent applications and has performed freedom-to-operate, patentability, non-infringement, validity, inventorship, and transactional due diligence analyses. Dr. Spenner also has experience with foreign patent oppositions, particularly in Australia. Prior to becoming an attorney and while attending law school part-time, Dr. Spenner worked full-time for over five years as a scientific advisor and patent agent at prominent law firms in New York City and at Leydig.
Technologies with which Dr. Spenner has experience include biologics, small molecule pharmaceuticals, recombinant proteins and nucleic acids, chimeric antigen receptors, antibodies, engineered cells, gene therapy, molecular biology techniques, medical diagnostics, personalized medicine, cosmetics, and wallboard manufacturing. His scientific background is multidisciplinary, exemplified by his doctoral dissertation research in biomacromolecular thermodynamics and structure, which culminated in a Ph.D. in molecular biophysics.
Dr. Spenner is on the Management Committee and oversees the Docketing Department of the firm.